2019年至今，卓越奖已表彰来自亚太各地的优秀研究者
因在肝纤维化分子机制研究中的系统性贡献，率先阐明关键信号通路的调控机制
主导开发针对东南亚高发型地中海贫血的基因诊断筛查方案，已在三国推广应用
领导设计并推行跨省慢性病社区管理干预模型，覆盖人口逾120万，效果显著
研发新型CRISPR递送平台，显著提升靶向精准性，相关专利已获多国授权
在神经退行性疾病早期预警生物标志物领域取得重要突破，开辟阿尔茨海默病早诊新路径
主导东南亚登革热防控综合干预研究，提出基于行为科学的社区参与模型并被WHO采纳参考
年仅31岁，独立主持开展单细胞多组学整合分析研究，成果发表于Cell Systems
带领团队将液体活检技术应用于鼻咽癌早期筛查，实现五年生存率大幅提升
Since 2019, the Excellence Awards have recognized outstanding researchers across the Asia-Pacific region.
Recognized for systematic contributions to the molecular mechanisms of liver fibrosis and early clarification of key signaling pathways.
Led the development of a genetic diagnostic screening program for thalassemia prevalent in Southeast Asia, now adopted in three countries.
Designed and implemented a cross-provincial chronic disease community intervention model covering more than 1.2 million people.
Developed a new CRISPR delivery platform that significantly improved targeting precision, with related patents granted in multiple countries.
Made important breakthroughs in early-warning biomarkers for neurodegenerative disease, opening a new route for early Alzheimer's diagnosis.
Led integrated dengue prevention research in Southeast Asia and proposed a behavior-science-based community participation model referenced by WHO.
At age 31, independently led single-cell multi-omics integration research published in Cell Systems.
Led the application of liquid biopsy technology for early nasopharyngeal carcinoma screening, significantly improving five-year survival outcomes.